NG
MD icon

NatWest Group’s Pediatrix Medical MD Stock Holding History

NatWest Group’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-14,392
Closed -$722K – 835
2013
Q3 		$722K Buy
+14,392
New +$702K 0.02% 547

Other funds holding MD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NatWest Group's MD Position: Q4 2013 in Review

NatWest Group sold out of Pediatrix Medical (MD) in Q4 2013, closing a stake of 14,392 shares — an estimated $722K sold.

NatWest Group first reported a position in MD in Q3 2013 and held it in 1 quarter. The position peaked at $722K in Q3 2013. 304 funds tracked by Wall St. Rank hold MD as of Q4 2013.

  • NatWest Group reported no remaining Pediatrix Medical position as of Q4 2013 after selling out during the quarter.
  • NatWest Group sold 14,392 Pediatrix Medical shares in Q4 2013, an estimated $722K.
  • NatWest Group first reported a position in Pediatrix Medical in Q3 2013 and held it in 1 quarter.
  • NatWest Group's Pediatrix Medical position peaked at $722K in Q3 2013.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2013.

Based on NatWest Group's 13F filing for Q4 2013, filed 13 Feb 2014.